Basic Information
LncRNA/CircRNA Name | MAPKAPK5-AS1 |
Synonyms | C12orf47 |
Region | GRCh38_12:111839764-111842902 |
Ensemble | ENSG00000234608 |
Refseq | NR_015404 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR, Western blot, RIP, other |
Sample | CRC tissues and cell lines (HCT116, SW480, HT-29, and DLD-1) |
Expression Pattern | up-regulated |
Function Description | Expression of MAPKAPK5-AS1 was significantly upregulated in 50 CRC tissues, and increased expression of MAPKAPK5-AS1 was found to be associated with greater tumor size and advanced pathological stage in CRC patients. Knockdown of MAPKAPK5-AS1 significantly inhibited proliferation and caused apoptosis in CRC cells. We also found that p21 is a target of MAPKAPK5-AS1. In addition, we are the first to report that MAPKAPK5-AS1 plays a carcinogenic role in CRC. |
Pubmed ID | 30343528 |
Year | 2019 |
Title | Long Noncoding RNA MAPKAPK5-AS1 Promotes Colorectal Cancer Proliferation by Partly Silencing p21 Expression |
External Links
Links for MAPKAPK5-AS1 | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |